This validation process confirmed reduced expression of the following five genes: Fmr1, Zfpm2, Wasl, Ets1 and Atg16l1 in the ABHF group compared to the ABLVH group (Fig. 4), suggesting a potential role of these genes in the development of systolic HF. The gene discussed is WASL; the disease is hydrops fetalis.